These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 31177811)

  • 1. Noninferiority Designed Cardiovascular Trials in Highest-Impact Journals.
    Bikdeli B; Welsh JW; Akram Y; Punnanithinont N; Lee I; Desai NR; Kaul S; Stone GW; Ross JS; Krumholz HM
    Circulation; 2019 Jul; 140(5):379-389. PubMed ID: 31177811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protocol adherence rates in superiority and noninferiority randomized clinical trials published in high impact medical journals.
    Bamat NA; Ekhaguere OA; Zhang L; Flannery DD; Handley SC; Herrick HM; Ellenberg SS
    Clin Trials; 2020 Oct; 17(5):552-559. PubMed ID: 32666826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-inferiority trials using a surrogate marker as the primary endpoint: An increasing phenotype in cardiovascular trials.
    Bikdeli B; Caraballo C; Welsh J; Ross JS; Kaul S; Stone GW; Krumholz HM
    Clin Trials; 2020 Dec; 17(6):723-728. PubMed ID: 32838556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noninferiority margins exceed superiority effect estimates for mortality in cardiovascular trials in high-impact journals.
    Ofori S; Cafaro T; Devereaux PJ; Marcucci M; Mbuagbaw L; Thabane L; Guyatt G
    J Clin Epidemiol; 2023 Sep; 161():20-27. PubMed ID: 37421996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing the Quality of Abstracts in Randomized Controlled Trials Published in High Impact Cardiovascular Journals.
    Khan MS; Shaikh A; Ochani RK; Akhtar T; Fatima K; Khan SU; Mookadam F; Murad MH; Figueredo VM; Doukky R; Krasuski RA
    Circ Cardiovasc Qual Outcomes; 2019 May; 12(5):e005260. PubMed ID: 31030545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Empirical Consequences of Current Recommendations for the Design and Interpretation of Noninferiority Trials.
    Aberegg SK; Hersh AM; Samore MH
    J Gen Intern Med; 2018 Jan; 33(1):88-96. PubMed ID: 28875400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Publication of noninferiority clinical trials: changes over a 20-year interval.
    Suda KJ; Hurley AM; McKibbin T; Motl Moroney SE
    Pharmacotherapy; 2011 Sep; 31(9):833-9. PubMed ID: 21923583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methodological reporting of randomized clinical trials in respiratory research in 2010.
    Lu Y; Yao Q; Gu J; Shen C
    Respir Care; 2013 Sep; 58(9):1546-51. PubMed ID: 23307824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reporting of noninferiority and equivalence randomized trials for major prostaglandins: a systematic survey of the ophthalmology literature.
    Eyawo O; Lee CW; Rachlis B; Mills EJ
    Trials; 2008 Dec; 9():69. PubMed ID: 19055743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-inferiority trials: are they inferior? A systematic review of reporting in major medical journals.
    Rehal S; Morris TP; Fielding K; Carpenter JR; Phillips PP
    BMJ Open; 2016 Oct; 6(10):e012594. PubMed ID: 27855102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unresolved issues with noninferiority pragmatic trials: Results of a literature survey.
    Ciarleglio MM; Li J; Peduzzi P
    Clin Trials; 2024 Apr; 21(2):242-256. PubMed ID: 37927102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The quality of reporting of trial abstracts is suboptimal: survey of major general medical journals.
    Berwanger O; Ribeiro RA; Finkelsztejn A; Watanabe M; Suzumura EA; Duncan BB; Devereaux PJ; Cook D
    J Clin Epidemiol; 2009 Apr; 62(4):387-92. PubMed ID: 19010643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of Multiplicity and Appropriate Adjustments Among Cardiovascular Randomized Clinical Trials Published in Major Medical Journals.
    Khan MS; Khan MS; Ansari ZN; Siddiqi TJ; Khan SU; Riaz IB; Asad ZUA; Mandrola J; Wason J; Warraich HJ; Stone GW; Bhatt DL; Kapadia SR; Kalra A
    JAMA Netw Open; 2020 Apr; 3(4):e203082. PubMed ID: 32301992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing the Justification, Funding, Success, and Survival Outcomes of Randomized Noninferiority Trials of Cancer Drugs: A Systematic Review and Pooled Analysis.
    Gyawali B; Tessema FA; Jung EH; Kesselheim AS
    JAMA Netw Open; 2019 Aug; 2(8):e199570. PubMed ID: 31469391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of reporting of noninferiority and equivalence randomized trials.
    Le Henanff A; Giraudeau B; Baron G; Ravaud P
    JAMA; 2006 Mar; 295(10):1147-51. PubMed ID: 16522835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global mapping of randomised trials related articles published in high-impact-factor medical journals: a cross-sectional analysis.
    Catalá-López F; Aleixandre-Benavent R; Caulley L; Hutton B; Tabarés-Seisdedos R; Moher D; Alonso-Arroyo A
    Trials; 2020 Jan; 21(1):34. PubMed ID: 31910857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COMPare: a prospective cohort study correcting and monitoring 58 misreported trials in real time.
    Goldacre B; Drysdale H; Dale A; Milosevic I; Slade E; Hartley P; Marston C; Powell-Smith A; Heneghan C; Mahtani KR
    Trials; 2019 Feb; 20(1):118. PubMed ID: 30760329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ensuring Superior Reporting of Radiation Therapy Noninferiority Trials: A Systematic Review.
    Arifin AJ; Tan VS; Yan M; Warner A; Boldt RG; Chen H; Rodrigues GB; Palma DA; Louie AV
    Adv Radiat Oncol; 2023; 8(3):101178. PubMed ID: 36852015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized trials published in higher vs. lower impact journals differ in design, conduct, and analysis.
    Bala MM; Akl EA; Sun X; Bassler D; Mertz D; Mejza F; Vandvik PO; Malaga G; Johnston BC; Dahm P; Alonso-Coello P; Diaz-Granados N; Srinathan SK; Hassouneh B; Briel M; Busse JW; You JJ; Walter SD; Altman DG; Guyatt GH
    J Clin Epidemiol; 2013 Mar; 66(3):286-95. PubMed ID: 23347852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. THE REPORTING QUALITY OF NONINFERIORITY TRIALS USING INTRAVITREAL VASCULAR ENDOTHELIAL GROWTH FACTOR INHIBITORS.
    Jia H; Li T; Wan H; Wu Z; Sun X
    Retina; 2023 Feb; 43(2):243-253. PubMed ID: 36695797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.